BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22664117)

  • 1. MicroRNAs in hematological malignancies: a novel approach to targeted therapy.
    Joshi D; Gosh K; Vundinti BR
    Hematology; 2012 May; 17(3):170-5. PubMed ID: 22664117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in hematological malignancies.
    Fatica A; Bozzoni I
    Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in hematological malignancies.
    Lawrie CH
    Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression and function in cancer.
    Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
    Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between microRNA-155 and hematological malignancies].
    Xue H; Hua LM; Luo JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
    Xie L; Jing R; Qi J; Lin Z; Ju S
    Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances on application of small RNA in research for hematological malignancies - review].
    Li ZJ; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1237-41. PubMed ID: 18928636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNAs in normal and malignant hematopoiesis.
    Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
    Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression profiling in bone marrow: implications in hematological malignancies.
    Costa A; Osório C; Dias S
    Biotechnol J; 2009 Jan; 4(1):88-97. PubMed ID: 19156746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research Progress on miR-125 Family in Malignant Hematologic Diseases-Review].
    Liu AF; Wang JX; Li FL; Chen YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1842-1846. PubMed ID: 29262928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microRNAs in normal hematopoiesis and hematopoietic malignancies.
    Kluiver J; Kroesen BJ; Poppema S; van den Berg A
    Leukemia; 2006 Nov; 20(11):1931-6. PubMed ID: 16990772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
    Barbarotto E; Calin GA
    Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-155 as a novel clinical target for hematological malignancies.
    Witten L; Slack FJ
    Carcinogenesis; 2020 Mar; 41(1):2-7. PubMed ID: 31711135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting microRNA in hematologic malignancies.
    Han Z; Rosen ST; Querfeld C
    Curr Opin Oncol; 2020 Sep; 32(5):535-544. PubMed ID: 32657797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNA-s and their role in malignant hematologic diseases].
    Gaál Z; Oláh E
    Orv Hetil; 2012 Dec; 153(52):2051-9. PubMed ID: 23261993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes.
    Ghaedi H; Bastami M; Zare-Abdollahi D; Alipoor B; Movafagh A; Mirfakhraie R; Omrani MD; Masotti A
    Genomics; 2015 Dec; 106(6):360-6. PubMed ID: 26520014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression signatures in solid malignancies.
    Galasso M; Sandhu SK; Volinia S
    Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.
    Dzikiewicz-Krawczyk A
    Crit Rev Oncol Hematol; 2015 Jan; 93(1):1-17. PubMed ID: 25217091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-29 family in hematological malignancies.
    Fiserova B; Kubiczkova L; Sedlarikova L; Hajek R; Sevcikova S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):184-91. PubMed ID: 25004911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.